Visit our Re-post guidelines
Up to 90% of colon cancer cases can be linked to diet. Let food be your medicine
Recently the U.S. Food and Drug Administration approved a new drug for metastatic colon cancer.
Lonsurf is a combination of two drugs, trifluridine and tipiracil. Its most common side effects are life-threatening anemia, a decrease in infection-fighting white blood cells and blood platelets, physical weakness, and extreme fatigue. It also causes nausea, decreased appetite, diarrhea, vomiting, abdominal pain and fever.